Author: National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (U.S.).Publisher:
ISBN:
Category :
Languages : en
Pages : 130
Book Description
Ethical guidelines for the delivery of health services by DHEW v. 1
Author: National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (U.S.).Publisher:
ISBN:
Category :
Languages : en
Pages : 130
Book Description
Ethical Guidelines for the Delivery of Health Services by DHEW
Author: United States. National Commission for the Protection of Human Subjects of Biomedical and Behavioral ResearchPublisher:
ISBN:
Category : Human experimentation in medicine
Languages : en
Pages : 128
Book Description
Appendix to Ethical Guidelines for the Delivery of Health Services by DHEW
Author: United States. National Commission for the Protection of Human Subjects of Biomedical and Behavioral ResearchPublisher:
ISBN:
Category : Health services administration
Languages : en
Pages : 370
Book Description
Ethical guidelines for the delivery of health services by DHEW v. 2
Author: National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (U.S.).Publisher:
ISBN:
Category :
Languages : en
Pages : 418
Book Description
The Belmont Report
Author: United States. National Commission for the Protection of Human Subjects of Biomedical and Behavioral ResearchPublisher:
ISBN:
Category : Ethics, Medical
Languages : en
Pages : 614
Book Description
Monthly Catalog of United States Government Publications
Author: Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 1282
Book Description
Society's Choices
Author: Institute of MedicinePublisher: National Academies Press
ISBN: 0309051320
Category : Medical
Languages : en
Pages : 560
Book Description
Breakthroughs in biomedicine often lead to new life-giving treatments but may also raise troubling, even life-and-death, quandaries. Society's Choices discusses ways for people to handle today's bioethics issues in the context of America's unique history and cultureâ€"and from the perspectives of various interest groups. The book explores how Americans have grappled with specific aspects of bioethics through commission deliberations, programs by organizations, and other mechanisms and identifies criteria for evaluating the outcomes of these efforts. The committee offers recommendations on the role of government and professional societies, the function of commissions and institutional review boards, and bioethics in health professional education and research. The volume includes a series of 12 superb background papers on public moral discourse, mechanisms for handling social and ethical dilemmas, and other specific areas of controversy by well-known experts Ronald Bayer, Martin Benjamin, Dan W. Brock, Baruch A. Brody, H. Alta Charo, Lawrence Gostin, Bradford H. Gray, Kathi E. Hanna, Elizabeth Heitman, Thomas Nagel, Steven Shapin, and Charles M. Swezey.
Antenatal Diagnosis
Author: Research Ethics
Author: Kenneth D. PimplePublisher: Routledge
ISBN: 1351904000
Category : Philosophy
Languages : en
Pages : 689
Book Description
This volume includes more than 40 important articles on integrity and misconduct, biomedical research, the social and disciplinary contexts of science, research in the social sciences, the social responsibility of science and scientists, and other core issues in research ethics. A new introduction by the editor places these articles in their historical and conceptual context. The volume provides a rich library of resources, ideas and challenges in the ethics of research for any scholar concerned with such issues.
The Law of Off-label Uses of Medicines
Author: Andrea ParzialePublisher: Taylor & Francis
ISBN: 1000634388
Category : Law
Languages : en
Pages : 183
Book Description
This book examines the regulatory framework for untested and unapproved uses (off-label uses) of medicines in the EU, UK, and USA. Before reaching patients, medicines are extensively tested by manufacturers and approved by regulators to minimise the risk of adverse reactions. However, physicians can prescribe pharmaceuticals for off-label uses, widespread in paediatrics, oncology, rare diseases and, more recently, in treatment for Covid-19. While off-label uses may offer hope, they may also expose patients to risks and uncertainties. Clarification is therefore needed to improve the protection of patients' rights while enhancing legal certainty for health actors. To this end, this work clarifies the regulatory mechanisms and litigation trends concerning off-licence prescriptions in these jurisdictions. It assesses how traditional, prevention-driven regulatory and civil liability rules are being adapted to tackle potential risks and scientific uncertainty. The book outlines the applicable regulations, as well as considering Brexit’s impact on off-label policies in the UK, and EU and national off-label policies in the context of the fight against the Covid-19 pandemic. It also explores under what conditions physicians, manufacturers, or regulators must compensate patients injured by untested prescriptions. The book will be an essential resource for researchers, academics and policy-makers working in the areas of medical law and ethics, public health law, pharmaceutical law and private comparative law.